[go: up one dir, main page]

FI940696L - New pyrazine derivatives, their preparation and use - Google Patents

New pyrazine derivatives, their preparation and use Download PDF

Info

Publication number
FI940696L
FI940696L FI940696A FI940696A FI940696L FI 940696 L FI940696 L FI 940696L FI 940696 A FI940696 A FI 940696A FI 940696 A FI940696 A FI 940696A FI 940696 L FI940696 L FI 940696L
Authority
FI
Finland
Prior art keywords
preparation
pyrazine derivatives
new pyrazine
new
derivatives
Prior art date
Application number
FI940696A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940696A7 (en
FI940696A0 (en
Inventor
Herbert Koeppe
Georg Speck
Klaus Stockhaus
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/en
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/en
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI940696A7 publication Critical patent/FI940696A7/en
Publication of FI940696L publication Critical patent/FI940696L/en
Publication of FI940696A0 publication Critical patent/FI940696A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
FI940696A 1991-08-16 1992-07-31 New pyrazine derivatives, their preparation and use FI940696A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (en) 1991-08-16 1991-08-16 New 3-amino-6-chloro:pyrazine 2-carboxamide derivs. - useful as hypotensive, mucolytic, diuretic and antitumoural drugs
DE19914130461 DE4130461A1 (en) 1991-09-13 1991-09-13 New 3-amino-5-substd. carboxamide chloro-pyrazine carbamide cpds.
PCT/EP1992/001738 WO1993004048A1 (en) 1991-08-16 1992-07-31 New pyrazine derivatives, their preparation and their use

Publications (3)

Publication Number Publication Date
FI940696A7 FI940696A7 (en) 1994-02-15
FI940696L true FI940696L (en) 1994-02-15
FI940696A0 FI940696A0 (en) 1994-02-15

Family

ID=25906394

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940696A FI940696A0 (en) 1991-08-16 1992-07-31 New pyrazine derivatives, their preparation and use

Country Status (22)

Country Link
EP (1) EP0598770B1 (en)
JP (1) JPH06509798A (en)
AT (1) ATE159250T1 (en)
AU (1) AU669122B2 (en)
CA (1) CA2115755A1 (en)
CZ (1) CZ280760B6 (en)
DE (1) DE59208974D1 (en)
DK (1) DK0598770T3 (en)
ES (1) ES2108129T3 (en)
FI (1) FI940696A0 (en)
GR (1) GR3025742T3 (en)
HU (1) HUT67661A (en)
IE (1) IE922592A1 (en)
IL (1) IL102814A0 (en)
MX (1) MX9204637A (en)
NO (1) NO301542B1 (en)
NZ (1) NZ243959A (en)
RU (1) RU2124008C1 (en)
SG (1) SG46307A1 (en)
SK (1) SK17594A3 (en)
TW (1) TW213903B (en)
WO (1) WO1993004048A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4337609A1 (en) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Novel pyrazinecarboxamide derivatives, their preparation and their use in medicines
DE4412334A1 (en) * 1994-04-11 1995-10-19 Hoechst Ag Substituted N-heteroaroylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
US5760230A (en) * 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
IT1312310B1 (en) * 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma USE OF SELECTIVE 1B ADRENERGIC RECEPTOR ANTAGONISTS TO IMPROVE SEXUAL DYSFUNCTION
CA2375702A1 (en) 1999-06-03 2000-12-14 Takeda Chemical Industries, Ltd. Nasal preparations
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
ATE521592T1 (en) * 2002-03-13 2011-09-15 Janssen Pharmaceutica Nv HISTONE DEACETYLASE INHIBITORS
AU2004253967B2 (en) 2003-07-03 2010-02-18 Cytovia, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
EP1667643A4 (en) 2003-08-28 2008-03-05 Nitromed Inc Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2597460A1 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
DE102008061247A1 (en) 2008-12-10 2010-06-24 Christian-Albrechts-Universität Zu Kiel Inhibitors of dimethylarginine dimethylaminohydrolase
DK2615092T3 (en) * 2010-09-10 2015-09-21 Hangzhou Bensheng Pharmaceutical Co Ltd Heterocyclic AMINOBERBAMIN DERIVATIVES, PREPARATION METHOD AND USE THEREOF
CN110041291B (en) * 2018-01-15 2021-02-26 北京采瑞医药科技研究院有限公司 Macamide derivative and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639386A (en) * 1962-10-30
US3527758A (en) * 1967-04-13 1970-09-08 Merck & Co Inc Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine
US3539569A (en) * 1968-08-21 1970-11-10 Merck & Co Inc Preparation of pyrazinoylguanidines from pyrazinoylureas
NL7803906A (en) * 1978-04-12 1979-10-16 Noordvos Schroeven Bv METHOD, DEVICE AND PROPELLER FOR DISTRIBUTING A GAS, POWDER OR LIQUID MATERIAL IN A LIQUID.
GB8712365D0 (en) * 1987-05-26 1987-07-01 Ici America Inc Aminomethylphenolic pyrazines

Also Published As

Publication number Publication date
EP0598770B1 (en) 1997-10-15
SK17594A3 (en) 1994-12-07
NO940523L (en) 1994-02-15
ES2108129T3 (en) 1997-12-16
FI940696A7 (en) 1994-02-15
HK1003137A1 (en) 1998-10-09
DE59208974D1 (en) 1997-11-20
ATE159250T1 (en) 1997-11-15
MX9204637A (en) 1993-02-01
CA2115755A1 (en) 1993-03-04
DK0598770T3 (en) 1997-12-15
EP0598770A1 (en) 1994-06-01
AU2387092A (en) 1993-03-16
IE922592A1 (en) 1993-02-24
AU669122B2 (en) 1996-05-30
NZ243959A (en) 1995-07-26
NO940523D0 (en) 1994-02-15
HU9400430D0 (en) 1994-05-30
FI940696A0 (en) 1994-02-15
GR3025742T3 (en) 1998-03-31
CZ280760B6 (en) 1996-04-17
RU2124008C1 (en) 1998-12-27
CZ33794A3 (en) 1994-07-13
NO301542B1 (en) 1997-11-10
SG46307A1 (en) 1998-02-20
RU94015265A (en) 1997-02-20
JPH06509798A (en) 1994-11-02
TW213903B (en) 1993-10-01
WO1993004048A1 (en) 1993-03-04
HUT67661A (en) 1995-04-28
IL102814A0 (en) 1993-01-31

Similar Documents

Publication Publication Date Title
FI955248A7 (en) 1-Biphenylmethylimidazole derivatives, their preparation and therapeutic use
FI923775A7 (en) 2-Piperazinone compounds, their preparation and use
FI935074A7 (en) New thiopyranopyrrole derivatives and their preparation
FI940696L (en) New pyrazine derivatives, their preparation and use
FI905770L (en) New isoindolone derivatives, their preparation and use
FI934426A7 (en) Thiazolidinedione derivatives, their preparation and use
FI935897L (en) Pyridopyrimidine derivatives, their preparation and use
FI955235L (en) Oxazolidinion derivatives, their preparation and use
FI952179A7 (en) New 3,3-diphenylpropylamines, their use and preparation
FI935887A7 (en) Thiazolidinedione derivatives, their preparation and use
FI921459A7 (en) Piperidine derivatives, their preparation and therapeutic use
FI922983A7 (en) Pyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI915099A7 (en) Thienoimidazole derivatives, their preparation and use
FI914611A7 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI940889A7 (en) New isazine oxime derivatives, their preparation and use
FI922982A7 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use
FI932145A7 (en) New b-carboline derivatives, their preparation and use in pharmaceuticals
FI934680A7 (en) Arylmorpholine, preparation and use
FI930716A7 (en) New arylcarbonylaminoalkyldihydrooxopyridines, their preparation and use
FI923458A7 (en) 4,5-cycloalkano-3-benzazepin-7-ol derivatives and their use
FI921814A7 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI920663A7 (en) Polyhydroxycyclopentane derivatives, their preparation and therapeutic use
FI941958A7 (en) 2-Heterocyclinenethylamine derivatives and their use as drugs
FI941963A7 (en) Pyridine derivatives, their preparation and use
FI923492A7 (en) Indole derivatives, their preparation and use